Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRHR | P34981 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ACE | P12821 | 5/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29630526 | 1.00 | TRHR (0.41) | TRHRTSHRACEACE2 | |
| SCHEMBL29630670 | 0.94 | TRHR (0.42) | TRHRTSHRACEACE2 | |
| SCHEMBL29630596 | 0.93 | MEN1 (0.43) | TRHRACE | |
| SCHEMBL30338091 | 0.90 | ACE (0.50) | TSHRACEACE2 | |
| SCHEMBL29630375 | 0.90 | TRHR (0.41) | TRHRACEACE2 | |
| SCHEMBL29958712 | 0.90 | TRHR (0.41) | TRHRACEACE2 | |
| SCHEMBL7759104 | 0.89 | DPP4 (0.42) | ACEACE2 | |
| SCHEMBL7759091 | 0.89 | DPP4 (0.42) | ACEACE2 | |
| SCHEMBL29630369 | 0.89 | TRHR (0.41) | TRHRTSHRACEACE2 | |
| SCHEMBL29701316 | 0.89 | ACE (0.49) | ACEACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12618102-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited (GB) | 2026-05-05 | — | — | US | disclosed |
| US-20220112547-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618102-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | POLM, POLR1A, POLR1E | TRHR 1057/4885TSHR 415/4885ACE 1009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.